Methods: Twenty-five homo-FH patients were recruited. LDLR mutations were identified using the Invader assay method. Mutations in PCSK9 were detected by PCR-SSCP followed by direct sequence analysis. 
Introduction
Familial hypercholesterolemia (FH) is an autosomal dominant disease characterized by the triad of (1) hypercholesterolemia due to a high level of plasma low-densitylipoprotein (LDL), (2) tendon xanthomas and (3) premature coronary heart disease [1] .
Patients with homozygous FH (homo-FH) have two mutant alleles of either of three FH-associated genes (FH genes), which are as follows: LDL-receptor (LDLR),
proprotein convertase subtilisin/kexin type 9 (PCSK9) and apolipoprotein B (ApoB)
gene [2] . Homo-FH patients are likely to be identified in early childhood because of the early appearance of xanthomatosis associated with an exceptionally high plasma cholesterol levels (exceeding 15.6 mmol/l), reflecting an extreme increase in LDL concentration. Use of the classical diagnosis of homo-FH and hetero-FH has led to an estimate of the prevalence of homo-and hetero-FH is 1 in 1,000,000 and 1 in 500 persons, respectively throughout the world [1] . 
Patients
Twenty-five clinically or genetically diagnosed homo-FH patients were selected for the study of genetic epidemiology of homo-FH and the calculation of the incidence of FH in the Hokuriku district. Written informed consent was obtained from each of the subjects prior to participation in the study.
Laboratory measurements
Blood samples for assays were drawn after overnight fasting. Concentrations of plasma total cholesterol (TC), triglyceride (TG) and high-density-lipoproteincholesterol (HDL-C) were determined at accredited clinical laboratories using routine clinical methods. LDL-cholesterol (LDL-C) concentrations were calculated using the Friedewald equation [5] .
FH genes analysis
Detailed methods of FH genes analysis were described in our previous paper [6] , and are described in brief here. Genomic DNA was prepared from white blood cells using a Genomic DNA Purification Kit (Gentra Systems, Minneapolis, MN, USA).
Primers covering all of the exons and exon-intron boundary sequence of LDLR and PCSK9 were designed using Primer3 online software (http://frodo.wi.mit.edu/). LDLR mutations were identified using the Invader assay method (Third Wave Technologies, Inc., Madison, WI, USA) for point mutations previously identified in Japan [7] . The multiplex ligation-dependent probe amplification (MLPA) method for large rearrangements was performed using a P062B LDLR MLPA kit (MRC Holland, Amsterdam, Netherlands) and DNA sequencing was performed using a BigDye
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) for the other mutations. ApoB mutations were screened by the methods reported in our previous paper [8] . Mutations in PCSK9 were detected by polymerase chain reaction (PCR) single-strand conformational polymorphism (SSCP) followed by direct sequence analysis.
Statistical analysis
Plasma lipid concentrations were compared among FH groups using Student's t-test.
All data in the text are expressed as mean ± SD. JMP 5.1.2 software (SAS Institute, Cary, NC, USA) was used for statistical analyses. p< 0.05 was considered statistically significant.
Results

Genotypic analyses of homo-FH patients
A DNA study of FH gene mutations was performed in all 25 clinically and genetically diagnosed homo-FH patients. Thirteen LDL-R mutants were found in these homo-FH patients, and one PCSK9 mutant (PCSK9 E32K) was found in five patients ( The outcomes of the patients are shown in Table 1 . Seven patients died of cardiac death and one (M.K.) died of leukemia. Seventeen patients are alive, and 6 patients have been treated with LDL-apheresis, and 11 patients with medications (Table 1) .
Frequency of FH calculated using the Hardy-Weinberg equilibrium
Among 11 true homo-FH families consanguineous marriage was detected in four. In the remaining seven families, there were no consanguineous marriages. In nine families of compound heterozygotes no consanguineous marriage was found (Table 1 , Fig. 1 ).
The Hardy-Weinberg equilibrium was used to calculate the frequency of hetero-FH. The 
Discussion
It has been thought that homo-FH is easily diagnosed. The prevalence of hetero-FH among the general population has been estimated to be at least, 1 in 500 among Caucasians, ranging from 1 in 200 to 1 in 1000 [11, 12] . In 1978, we summarized 51 homozygous patients with FH in Japan, and estimated the frequency of homo-FH in Japan as 1 in 1.45 millions, and that of hetero-FH as 1 in 500
[9]. However, the low incidence of FH in most countries is due to the low frequency of homo-FH diagnosed by classical diagnostic criteria based on physical signs, laboratory findings and data from the parents. In the present study genetic diagnosis detected unexpectedly mild phenotypic cases of homo-FH, and several new cases of homo-FH were discovered. As FH is an autosomal dominant genetic disease, the frequency of hetero-FH has been calculated by the incidence of homo-FH in the district using the Hardy-Weinberg equilibrium. Here we found an extraordinarily high incidence of FH in this district of Japan.
A remarkably high prevalence of FH has been reported in several areas of the world, owing to founder effects. In Lebanon, the estimated prevalence of homozygotes and heterozygotes is 1 in 10,000 and 1 in 171, respectively [13] . In the Hokuriku district of Japan, the most frequent mutation in hetero-FH was the K790X LDLR mutation, with a frequency of 31.7% [7] . However, this mutant was less frequent in the Osaka district These observations underline the value of gene analysis in diagnosing hetero-and homo-FH patients and the extraordinarily high frequency of FH in this district of Japan.
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